Increased bronchial NO output in severe atopic eczema in children and adolescents

Pediatric Allergy and Immunology

Volumn 19, Issue 5, 2008, Pages 426-432

  Linkosalo, Laura ^a   Lehtimäki, Lauri ^a   Laitinen, Jukka ^a,b   Kaila, Minna ^a   Holm, Kati ^b   Moilanen, Eeva ^a,c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b University of Tempere ^*  (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Atopic eczema; Atopy; Breath condensate; Bronchial inflammation; Exhaled nitric oxide

Indexed keywords

CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X; IMMUNOGLOBULIN E; MYELOPEROXIDASE; NITRIC OXIDE; PEPTIDOLEUKOTRIENE;

ADOLESCENT; ADULT; AIRFLOW; ARTICLE; ATOPIC DERMATITIS; BRONCHUS; CALCULATION; CLINICAL OBSERVATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPIRED AIR; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUNG ALVEOLUS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SCHOOL CHILD; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ANIMALS; ASTHMA; CHILD; CYSTEINE; DERMATITIS, ATOPIC; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL-DERIVED NEUROTOXIN; EXHALATION; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION; LEUKOTRIENES; MALE; NITRIC OXIDE; PULMONARY ALVEOLI; SEVERITY OF ILLNESS INDEX; SKIN TESTS; SPIROMETRY; STATISTICS AS TOPIC;

EID: 47249113467     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2007.00672.x     Document Type: Article

References (35)

1. Kyllönen H, Malmberg P, Remitz A, et al. Respiratory symptoms, bronchial hyper-responsiveness, and eosinofilic airway inflammation in patients with moderate to severe atopic dermatitis. Clin Exp Allergy 2006:36:192 7.
2. Weiland SK, von Mutius E, Hirsch T, et al. Prevalence of respiratory and atopic disorders among children in the East and West Germany five years after unification. Eur Respir J 1999:14:862 70.
3. Busse W, Kraft M. Cysteinyl leukotrienes in allergic inflammation. Chest 2005:127:1312 26.
4. Korhonen R, Lahti A, Kankaanranta H, Moilanen E. Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 2005:4:471 9.
5. Zitt M. Clinical applications of exhaled nitric oxide for the diagnosis and management of asthma: a consensus report. Clin Ther 2005:27:1238 50.
6. Frank TL, Adisesh A, Pickering AC, et al. Relationship between exhaled nitric oxide and childhood asthma. Am J Respir Crit Care Med 1998:158:1032 6.
7. Cardinale F, Benedictis FM, Muggeo V, et al. Exhaled nitric oxide, total serum IgE and allergic sensitization in childhood asthma and allergic rhinitis. Pediatr Allergy Immunol 2005:16:236 42.
8. Moody A, Fergusson W, Wells A, Bartley J, Kolbe J. Increased nitric oxide production in the respiratory track in asymptomatic Pacific Islanders. An association with skin prick reactivity to house dust mite. J Allergy Clin Immunol 2000:105:895 9.
9. Barreto M, Villa MP, Monti F, et al. Additive effect of eosinophilia and atopy on exhaled nitric oxide levels in children with or without a history of respiratory symptoms. Pediatr Allergy Immunol 2005:16:52 8.
10. Malmberg LP, Petäys T, Haahtela T, et al. Exhaled nitric oxide in healthy non-atopic school-age children: determinants and height-adjusted reference values. Pediatr Pulmonol 2006:41:635 42.
11. American Thoracic Society and European Respiratory Society ATS/ERS Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005:171:912 30.
12. Lehtimäki L. Measurement of exhaled nitric oxide: Acta Univ Tamperensis, 925, 2003. Available at: http://acta.uta.fi/pdf/951-44-5645-9.pdf
13. George SC, Högman M, Permutt S, Sillkoff PE. Modeling pulmonary nitric oxide exchange. J Appl Physiol 2004:96:831 9.
14. Tsoukias NM, George SC. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 1998:85:653 66.
15. Lehtimäki L, Kankaanranta H, Saarelainen S, et al. Extended exhaled NO measurements differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med 2001:163:1557 61.
16. Silkoff PE, Sylvester JT, Zamel N, Permutt S. Airway nitric oxide diffusion in asthma, role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med 2000:161:1218 28.
17. Högman M, Holmkvist T, Wegener T, et al. Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis. Respir Med 2002:96:24 30.
18. Pedroletti C, Högman M, Meriläinen P, Nordvall LS, Hedlin G, Alving K. Nitric oxide airway diffusing capacity and mucosal concentration in asthmatic schoolchildren. Pediatr Res 2003:54:496 501.
19. Koillinen H, Wanne O, Niemi V, Laakkonen E. Terveiden suomalaislasten spirometrian ja uloshengityksen huippuvirtauksen viitearvot. Suomen Lääkärilehti 1998:39:395 402 Normal values of spirometry examinations in healthy Finnish children. J Finn Med Assoc 1998:39:395 402).
20. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993:6:1368 70.
21. Lehtimäki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J 2001:18:635 9.
22. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005:352:2163 73.
23. Pijnenburg MW, Bakker EM, Hop WC, de Jongste JC. Titrating steroids on exhaled nitric oxide in children with asthma. Am J Respir Crit Care Med 2005:172:831 6.
24. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000:161:64 72.
25. Silvestri M, Spallarossa D, Frangova Yourukova V, Battistini E, Fregonese B, Rossi GA. Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermittent asthma. Eur Respir J 1999:13:321 6.
26. Payne DNR, Adcock IM, Wilson NM, Oates T, Scallann M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001:164:1376 81.
27. Lehtimäki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms. Eur Respir J 2002:20:841 5.
28. Mahut B, Delacourt C, Zerah-Lancner F, de Blic J, Harf A, Delclaux C. Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma. Chest 2004:125:1012 8.
29. Sepponen A, Lehtimäki L, Lehtonen H, Kaila M. Normal values of alveolar nitric oxide concentration and bronhial nitric oxide flux in healthy children measured with multiple exhalation flow rate method. Eur Respir J 2004:24 (Suppl. 48 375.
30. Horvath I, Hunt J, Barnes PJ, et al. ATS/ERS Task Force on exhaled breath condensate. Exhaled breath condensate: methological recommendations and unresolved questions. Eur Respir J 2005:26:523 48.
31. Meltzer EO. Role for cysteinyl leukotriene reseptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of "one linked airway disease". Ann Allergy Asthma Immunol 2000:84:176 85.
32. Csoma Z, Kharitonov SA, Balint B, Bush A, Wilson NM, Barnes PJ. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2002:166:1345 9.
33. Baraldi E, Carraro S, Alinovi R, et al. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003:58:505 9.
34. Zanconnato S, Carraro S, Corradi M, et al. Leucotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol 2004:113:257 63.
35. Sandrini A, Ferreira IM, Gutierrez C, Jardim JR, Zamel N, Chapman KR. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest 2003:124:1334 40.